Monday, December 28, 2020 6:40:24 PM
It may be in the Charles Cotropia Interview in that CEO-CFO Magazine.
I need to re-read/study it again & find that sentence.
But certainly this Article that you pointed out is very important, too, as it does state ENZC has "fully" human monoclonal antibodies. The word "fully" is very important here, because perhaps while these other pharma co's like Lilly & Regeneron do use some human cells, NOT ALL the derivatives used in their formularies are from human beings. THIS may be the distinction~ i.e., that ENZC's Patent is the ONLY one that uses ALL human derivatives in its formulary for its cure for COVID & other infectious diseases.
AND ENZC's Patent or formulary is the ONLY ONE that STARTS with a HUMAN-BEING's Cell~ the "B-Cell". ALL the other pharma co's START with some foreign-body tissue or NON-human substance, & then may add some human cellular component.
THIS is just one of the reasons why ENZC-BioClonetics' monoclonal antibody cure is so uniquely valuable~ it has NO Side-Effects (or hardly any, if at all). Therefore, it is completely 100% SAFE!
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM